Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

V Lomakin

Showing results (91-100 of 93) with videos related to

Pageof 10
Sort By:
You have reached the last page of results.This site can display upto 93 results.
Inflammation Research : Official Journal of the European Histamine Research Society ... [Et Al.]|September 29, 2021
The efficacy and safety of levilimab in severely ill COVID-19 patients not requiring mechanical ventilation: results of a multicenter randomized double-blind placebo-controlled phase III CORONA clinical studyNikita V Lomakin, Bulat A Bakirov, Denis N Protsenko, et al.
Vaccines|May 27, 2023
Assessment of Safety and Prophylactic Efficacy of the EpiVacCorona Peptide Vaccine for COVID-19 Prevention (Phase III)Alexander B Ryzhikov, Evgeny A Ryzhikov, Marina P Bogryantseva, et al.
Microorganisms|September 28, 2024
Effect of Opaganib on Supplemental Oxygen and Mortality in Patients with Severe SARS-CoV-2 Based upon FIO<sub>2</sub> RequirementsFernando Carvalho Neuenschwander, Ofra Barnett-Griness, Stefania Piconi, et al.
Pageof 10

Showing results (91-100 of 93) with videos related to

Sort By:
Pageof 10
You have reached the last page of results.This site can display upto 93 results.
Inflammation Research : Official Journal of the European Histamine Research Society ... [Et Al.]|September 29, 2021
The efficacy and safety of levilimab in severely ill COVID-19 patients not requiring mechanical ventilation: results of a multicenter randomized double-blind placebo-controlled phase III CORONA clinical studyNikita V Lomakin, Bulat A Bakirov, Denis N Protsenko, et al.
Vaccines|May 27, 2023
Assessment of Safety and Prophylactic Efficacy of the EpiVacCorona Peptide Vaccine for COVID-19 Prevention (Phase III)Alexander B Ryzhikov, Evgeny A Ryzhikov, Marina P Bogryantseva, et al.
Microorganisms|September 28, 2024
Effect of Opaganib on Supplemental Oxygen and Mortality in Patients with Severe SARS-CoV-2 Based upon FIO<sub>2</sub> RequirementsFernando Carvalho Neuenschwander, Ofra Barnett-Griness, Stefania Piconi, et al.
Pageof 10